Barclays raises BlackRock stock price target on strong fee growth By Investing.com

Barclays raised BlackRock’s price target to $1,310 from $1,290 while keeping an Overweight rating, citing Q2 EPS of $12.53, which beat estimates by 9%. Organic base fee growth of 8% marked the seventh straight quarter above 5%, supported by stronger international and emerging-markets flows and continued demand in private credit. BlackRock’s dividend streak now stands at 16 consecutive years, with the stock at $1,054.56 and a market cap of $171.87 billion.

Analysis

The market is treating this as a clean earnings beat, but the more important signal is that fee growth is becoming more resilient even in a late-cycle asset-gathering environment. That matters because BlackRock’s operating leverage is increasingly driven by mix, not just market beta: higher-fee international, EM, and private-market exposure can keep base-fee growth above nominal AUM growth for several quarters if risk assets stay rangebound. The stock’s rerating still has room, but the easy multiple expansion likely comes from proof that this mix shift is durable rather than a one-quarter print.

The real second-order issue is private credit. If institutional demand remains strong while public-market spreads stay compressed, BlackRock can keep monetizing the narrative without needing retail participation — but that also means the bull case is vulnerable to any sign of fundraising fatigue or fee compression in flagship vehicles. In other words, the debate isn’t about whether private credit is a good product; it’s whether the growth rate can stay high enough to justify the current premium multiple versus other asset managers. A few weak datapoints across peers over the next 1-2 earnings cycles would be enough to cap upside.

Consensus is likely underestimating how much of BLK’s earnings quality is now tied to capital returns and recurring fees rather than market-sensitive performance fees. That should reduce downside in a selloff, but it also means the stock may not respond as explosively to a risk-on tape as it did historically. The cleaner trade is to own BLK for compounding and dividend support, while being careful not to pay for an acceleration that may already be largely reflected in estimates.

Barclays’ upward revision is also a subtle signal for the rest of the sell-side: if the company can keep growing fees at this pace, comparable platforms with weaker product breadth may face relative valuation pressure. That creates a modest long/short opportunity in the asset-management space, especially if the next round of flows confirms that the winners are taking share in higher-fee sleeves rather than just rising with the market.

Key Decisions for Investors

• Add BLK on any 2-3% pullback; target 6-12 month upside to the revised Street range with downside cushioned by recurring fee growth and dividend support. Best risk/reward is on weakness, not chasing strength.
• Pair trade: long BLK / short a lower-quality traditional asset manager basket over 3-6 months. The setup favors platforms with diversified fee engines and exposure to higher-fee alternatives as fundraising data differentiates winners from laggards.
• Use BLK Jan-2027 call spreads rather than outright calls if you want upside exposure. The name should grind higher, but implied valuation already prices in a good portion of the private-markets narrative.
• Monitor private-credit fundraising and performance-fee commentary across earnings season; if two or more large peers flag slower inflows, trim BLK by 20-30% as the multiple expansion thesis becomes less defensible.
• For low-vol income accounts, hold BLK as a quality compounder versus more cyclical financials. The trade is fundamentally about recurring fee durability, not a near-term catalyst-driven pop.